Donor-Derived Acute Promyelocytic Leukemia in a Liver-Transplant Recipient
Imre Bodó, M.D., Marion Peters, M.D., Jerald P. Radich, M.D., Jay Hess, M.D., Morey Blinder, M.D., Michael S. Watson, Ph.D., Richard Van Rheeden, Shanti Natarajan, M.D., Jeffrey A. Lowell, M.D., Randy Brown, M.D., John DiPersio, M.D., Ph.D., and Douglas Adkins, M.D.
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
The long-term survival of donor lymphoid cells in recipientsof solid-organ transplants or of fetal lymphocytes that crossthe placenta and enter the maternal circulation has been established,1,2,3but the fate of other hematopoietic progenitors in organ allografts,especially those of the myeloid lineage, is not known. We describea case in which acute promyelocytic leukemia developed in arecipient of a liver transplant two years after transplantation.The leukemic clone had genetic and phenotypic markers of thedonor, a previously healthy 16-year-old boy who died of a headinjury. Our findings indicate that leukemic transformation ofdonor myeloid cells . . . [Full Text of this Article]
Case Report
Methods
Tissue Samples
Cytogenetic Analysis
DNA and RNA Extraction
Assay for Variable Number of Tandem Repeats and Molecular HLA Typing
Analysis by Reverse-Transcription PCR
Immunohistochemical Analysis
Fluorescence in Situ Hybridization
Results
Cytogenetic Analysis
VNTR Assay
RT-PCR Analysis
Molecular HLA Typing
Immunohistochemical Analysis and Fluorescence in Situ Hybridization
Discussion
Source Information
From the Departments of Medicine (I.B., M.P., M.B., S.N., R.B., J.D., D.A.), Pathology (J.H.), Pediatrics (M.S.W., R.V.R.), and Surgery (J.A.L.), Washington University School of Medicine, St. Louis; and the Fred Hutchinson Cancer Research Center, Seattle (J.P.R.).
Address reprint requests to Dr. Bodó at Euro-Med-Net, 5-7 Gyóri Ut., Budapest H-1123, Hungary, or at bodoimre@elender.hu.
References
This article has been cited by other articles:
Zhang, Y., Holford, T. R., Leaderer, B., Boyle, P., Zahm, S. H., Owens, P. H., Morton, L. M., Zhang, B., Zou, K., Flynn, S., Tallini, G., Zheng, T.
(2004). Blood Transfusion and Risk of Non-Hodgkin's Lymphoma in Connecticut Women. Am J Epidemiol
160: 325-330
[Abstract][Full Text]
Au, W.Y., Hung, K.N., Loong, F., Ma, S.K.
(2003). Patients Presenting With CNS Lesions: CASE 3. SEQUENTIAL MYELOPROLIFERATIVE DISEASE AND GLIOBLASTOMA MULTIFORME IN A RENAL TRANSPLANT RECIPIENT. JCO
21: 4062-4063
[Full Text]
Chow, E. J., Holly, E. A.
(2002). Blood Transfusions and Non-Hodgkin's Lymphoma. Epidemiol Rev
24: 269-279
[Full Text]
Chow, E. J., Holly, E. A.
(2002). Blood Transfusions as a Risk Factor for Non-Hodgkin's Lymphoma in the San Francisco Bay Area: A Population-based Study. Am J Epidemiol
155: 725-731
[Abstract][Full Text]
Berg, K. D., Brinster, N. K., Huhn, K. M., Goggins, M. G., Jones, R. J., Makary, A., Murphy, K. M., Griffin, C. A., Rosenblum-Vos, L. S., Borowitz, M. J., Nousari, H. C., Eshleman, J. R.
(2001). Transmission of a T-Cell Lymphoma by Allogeneic Bone Marrow Transplantation. NEJM
345: 1458-1463
[Full Text]
Nierhoff, D., Horvath, H. C., Mytilineos, J., Golling, M., Bud, O., Klar, E., Opelz, G., Voso, M. T., Ho, A. D., Haas, R., Hohaus, S.
(2000). Microchimerism in bone marrow-derived CD34+ cells of patients after liver transplantation. Blood
96: 763-767
[Abstract][Full Text]